Janus Kinase Inhibitor [EPC] - N0000190858

Name: Table of NDC products with janus kinase inhibitor
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000190858
Pharmacologic Name	Janus Kinase Inhibitor
Pharmacologic Uses	Janus kinase (JAK) inhibitor kinase inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Janus Kinase Inhibitor

The table contains 22 products whose active ingredient are classified under the same pharmacologic class Janus Kinase Inhibitor [EPC].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0002-4182	Olumiant	Non-Proprietary Name: Baricitinib	Tablet, Film Coated	Oral	Eli Lilly And Company	ACTIVE
0002-4479	Olumiant	Non-Proprietary Name: Baricitinib	Tablet, Film Coated	Oral	Eli Lilly And Company	ACTIVE
0002-4732	Olumiant	Non-Proprietary Name: Baricitinib	Tablet, Film Coated	Oral	Eli Lilly And Company	ACTIVE
0002-6885	Baricitinib	Non-Proprietary Name: Baricitinib	Tablet, Film Coated	Oral	Eli Lilly And Company	ACTIVE
0069-0235	Cibinqo	Non-Proprietary Name: Abrocitinib	Tablet, Film Coated	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-0335	Cibinqo	Non-Proprietary Name: Abrocitinib	Tablet, Film Coated	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-0435	Cibinqo	Non-Proprietary Name: Abrocitinib	Tablet, Film Coated	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-0501	Xeljanz XR	Non-Proprietary Name: Tofacitinib	Tablet, Film Coated, Extended Release	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-0502	Xeljanz XR	Non-Proprietary Name: Tofacitinib	Tablet, Film Coated, Extended Release	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-1001	Xeljanz	Non-Proprietary Name: Tofacitinib	Tablet, Film Coated	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-1002	Xeljanz	Non-Proprietary Name: Tofacitinib	Tablet, Film Coated	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-1029	Xeljanz	Non-Proprietary Name: Tofacitinib	Solution	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
50881-005	Jakafi	Non-Proprietary Name: Ruxolitinib	Tablet	Oral	Incyte Corporation	ACTIVE
50881-007	Opzelura	Non-Proprietary Name: Ruxolitinib	Cream	Topical	Incyte Corporation	ACTIVE
50881-010	Jakafi	Non-Proprietary Name: Ruxolitinib	Tablet	Oral	Incyte Corporation	ACTIVE
50881-015	Jakafi	Non-Proprietary Name: Ruxolitinib	Tablet	Oral	Incyte Corporation	ACTIVE
50881-020	Jakafi	Non-Proprietary Name: Ruxolitinib	Tablet	Oral	Incyte Corporation	ACTIVE
50881-025	Jakafi	Non-Proprietary Name: Ruxolitinib	Tablet	Oral	Incyte Corporation	ACTIVE
63539-012	Xeljanz	Non-Proprietary Name: Tofacitinib	Tablet, Film Coated	Oral	U.s. Pharmaceuticals	ACTIVE
63539-016	Xeljanz	Non-Proprietary Name: Tofacitinib	Tablet, Film Coated	Oral	U.s. Pharmaceuticals	ACTIVE
63539-501	Xeljanz XR	Non-Proprietary Name: Tofacitinib	Tablet, Extended Release	Oral	U.s. Pharmaceuticals	ACTIVE
63539-502	Xeljanz XR	Non-Proprietary Name: Tofacitinib	Tablet, Extended Release	Oral	U.s. Pharmaceuticals	ACTIVE